The Biology, Origins, and Subtypes of Ovarian Cancer

While often referred to as a single disease, “ovarian cancer” is actually an umbrella term for a collection of distinct malignancies that happen to involve the ovaries ^[1][2]. These cancers differ significantly in where they start, how they behave, and which genetic mutations drive them. Understanding the specific biology of your tumor is essential, as it helps your medical team tailor your treatment.

The Dualistic Model: Type I vs. Type II

Scientists use a dualistic model to categorize the most common forms of ovarian cancer (epithelial cancers) into two main groups ^[3][4]:

• Type I Tumors: These are typically slower-growing and often develop from precursor lesions like endometriosis or borderline tumors ^[4]. This group includes low-grade serous, endometrioid, clear cell, and mucinous carcinomas ^[3].
• Type II Tumors: These are highly aggressive and much more common. The most frequent subtype is High-Grade Serous Ovarian Carcinoma (HGSOC) ^[3]. These tumors are frequently diagnosed at an advanced stage and are genetically unstable.

The “Tubal Origin” Breakthrough

For decades, it was believed that most ovarian cancers started on the surface of the ovary. However, a major shift in medical understanding—the tubal origin hypothesis—suggests that most high-grade serous cancers actually begin in the fallopian tubes ^[5][6].

Researchers have identified precursor lesions called Serous Tubal Intraepithelial Carcinoma (STIC) at the fimbriated (finger-like) ends of the tubes ^[7][6]. Over time, these early cancer cells migrate from the fallopian tube to the surface of the ovary or the lining of the abdomen. This discovery has radically changed how doctors think about prevention, including the option for some patients to have their fallopian tubes removed (prophylactic salpingectomy) to reduce risk ^[8][9].

Major Subtypes of Ovarian Cancer

Epithelial Tumors

Epithelial tumors are the most common and arise from the cells that line the reproductive organs.

• High-Grade Serous (HGSOC): The most frequent and aggressive subtype. It typically responds well initially to chemotherapy but requires maintenance therapy ^[6].
• Clear Cell and Endometrioid: These subtypes exhibit distinct metabolomic landscapes and are often associated with endometriosis ^[10][11]. They have different genetic drivers than serous cancers.

Non-Epithelial Tumors

These cancers are less common and typically occur in younger individuals.

• Germ Cell Tumors: These arise from the germ cells (the cells that become eggs). They share some genetic alterations with epithelial tumors but are often highly curable with timely, optimal treatment ^[12][13].
• Sex Cord-Stromal Tumors (SCSTs): These develop from the structural tissues that hold the ovary together and produce hormones. They are frequently associated with specific mutations (like ARID1A and SMARCA4) and may cause unique symptoms like virilization (facial hair growth) due to hormone production ^[12][14].

Why the Subtype Matters

Knowing your subtype is more than just a label—it dictates your treatment pathway. Ovarian cancer is increasingly recognized as a collection of distinct diseases, each requiring targeted strategies based on their unique histopathological and molecular features ^[1]. By identifying the specific biology of your cancer, your care team can ensure you receive the most precise care possible.